- Application of a Proapoptotic Peptide to Intratumorally Spreading Cancer Therapy.Chen R, Braun G, Luo X, Sugahara KN, Teesalu T, Ruoslahti E. Cancer Res. 2012 Dec 17.
- De Novo Design of a Tumor-Penetrating Peptide. Alberici L, Roth L, Sugahara KN, Agemy L, Kotamraju VR, Teesalu T, Bordignon C, Traversari C, Rizzardi GP, Ruoslahti E. Cancer Res. 2012 Nov 14. [Epub ahead of print]
- Mapping of vascular ZIP codes by phage display. Teesalu T, Sugahara KN, Ruoslahti E. Methods Enzymol. 2012;503:35-56.
- Transtumoral targeting enabled by a novel neuropilin-binding peptide.Roth L, Agemy L, Kotamraju VR, Braun G, Teesalu T, Sugahara KN, Hamzah J, Ruoslahti E.Oncogene. 2012 Aug 16;31(33):3754-63.
- Selection of phage-displayed peptides on live adherent cells in microfluidic channels. Wang J, Liu Y, Teesalu T, Sugahara KN, Kotamrajua VR, Adams JD, Ferguson BS, Gong Q, Oh SS, Csordas AT, Cho M, Ruoslahti E, Xiao Y, Soh HT. Proc Natl Acad Sci U S A. 2011 Apr 26;108(17):6909-14.
- A high-throughput label-free nanoparticle analyser. Fraikin JL, Teesalu T, McKenney CM, Ruoslahti E, Cleland AN. Nat Nanotechnol. 2011 May;6(5):308-13.
- Binding of a C-end rule peptide to the neuropilin-1 receptor: a molecular modeling approach. Haspel N, Zanuy D, Nussinov R, Teesalu T, Ruoslahti E, Aleman C. Biochemistry. 2011 Mar 15;50(10):1755-62.
- Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs. Sugahara KN, Teesalu T, Karmali PP, Kotamraju VR, Agemy L, Greenwald DR, Ruoslahti E. Science. 2010 May 21;328(5981):1031-5.
- Tissue-penetrating delivery of compounds and nanoparticles into tumors. Sugahara KN, Teesalu T, Karmali PP, Kotamraju VR, Agemy L, Girard OM, Hanahan D, Mattrey RF, Ruoslahti E. Cancer Cell. 2009 Dec 8;16(6):510-20.
- C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration. Teesalu T, Sugahara KN, Kotamraju VR, Ruoslahti E. Proc Natl Acad Sci U S A. 2009 Sep 22;106(38):16157-62.
Wednesday, 09 January 2013 02:00